ENTPD3 and colorectal carcinoma: Digging deeper into the role of the T2DM and CRC core gene ENTPD3 in CRC anti-tumor immunity would be instrumental in optimizing the clinical values of ICIs in the era of immunotherapy, whether in terms of predictive biomarkers or improving immunotherapy efficiency.